
|Articles|December 2, 2016
Rheumatoid Arthritis Biosimilar Development Highlights Week in Specialty Pharmacy
Author(s)Davy James, Managing Editor
Top news of the week on Specialty Pharmacy Times.
Advertisement
[<a href="//storify.com/pharmacytimes/rheumatoid-arthritis-biosimilar-development-highli" target="_blank">View the story "Rheumatoid Arthritis Biosimilar Development Highlights Week in Specialty Pharmacy" on Storify</a>]
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Pharmacists at the Forefront: Initiating, Monitoring, and Identifying Candidates for VMAT2 Therapy
2
FDA Accepts NDA for AD109 for Treatment of Adults With Obstructive Sleep Apnea
3
Workforce Preparation for Fall Immunization Season Starts Now
4
Investigational mRNA Flu Vaccine Broadens Antibody Defenses, Sustains Immune "Training Hub" Longer Than Standard Shot
5






































































































